A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC

NCT05205629 · clinicaltrials.gov ↗
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Zhongshan Hospital